CG
VCYT icon

Caprock Group’s Veracyte VCYT Stock Holding History

Caprock Group’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$213K Sell
6,606
-442
-6% -$16.4K 0.01% 1036
2025
Q4 		$297K Buy
7,048
+185
+3% +$7.46K 0.01% 1005
2025
Q3 		$208K Buy
+6,863
New +$197K 0.01% 1052
2025
Q1 		$205K Buy
6,915
+63
+0.9% +$2.4K 0.01% 1001
2024
Q4 		$271K Sell
6,852
-555
-7% -$21K 0.01% 843
2024
Q3 		$252K Buy
+7,407
New +$208K 0.01% 777

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Caprock Group's VCYT Position: Q1 2026 in Review

Caprock Group reduced its Veracyte (VCYT) stake by 6.3% in Q1 2026, selling an estimated $16.4K and leaving 6,606 shares worth $213K. The position accounts for 0.01% of the portfolio, ranked #1036.

Caprock Group first reported a position in VCYT in Q3 2024 and has held it in 6 quarters since. The position peaked at $297K in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Caprock Group held 6,606 shares of Veracyte worth $213K as of Q1 2026.
  • Caprock Group sold 442 Veracyte shares in Q1 2026, an estimated $16.4K.
  • Veracyte made up 0.01% of Caprock Group's portfolio in Q1 2026, its #1036 holding.
  • Caprock Group first reported a position in Veracyte in Q3 2024 and has held it in 6 quarters since.
  • Caprock Group's Veracyte position peaked at $297K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.